Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Piperacillin/tazobactam in the treatment of hospitalized patients with urinary tract infections: an open non-comparative and multicentered trial.

Sifuentes-Osornio J, Jakob E, Clara L, Durlach R, Dain A, Ruìz-Palacios GM, Barkan L, Lamberghini R, Jáuregui A, Villalobos Y, Sáenz-Aguirre C, de la Cabada FJ, Rodríguez-Toledo A, Zavala-Trujillo I, Gamboa MA, Fuentes del Toro S, Froiler C, Maglio F, Quiroga JV, Rojas JJ, Conde-Carmona I.

J Chemother. 1996 Apr;8(2):122-9.

PMID:
8708743
[PubMed - indexed for MEDLINE]
2.

Piperacillin/tazobactam in the treatment of lower respiratory tract infections: an open non-comparative and multicentered trial. Latin American Clinical Research Group.

Sifuentes-Osornio J, Ruíz-Palacios GM, Jakob E, Rojas JJ, Jáuregui A, Villalobos Y.

J Chemother. 1994 Jun;6(3):197-203.

PMID:
7983503
[PubMed - indexed for MEDLINE]
3.
4.

Efficacy, safety and tolerance of parenteral piperacillin/tazobactam in the treatment of patients with lower respiratory tract infections.

Mouton Y, Leroy O, Beuscart C, Chidiac C, Senneville E, Ajana F, Lecocq P.

J Antimicrob Chemother. 1993 Jan;31 Suppl A:87-95.

PMID:
8383658
[PubMed - indexed for MEDLINE]
5.

Piperacillin/tazobactam in complicated urinary tract infections.

Nowé P.

Intensive Care Med. 1994 Jul;20 Suppl 3:S39-42.

PMID:
7962988
[PubMed - indexed for MEDLINE]
6.

A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.

Hou F, Li J, Gao L, Chen Y.

Chin Med J (Engl). 1998 Nov;111(11):1039-43.

PMID:
11189212
[PubMed - indexed for MEDLINE]
Free Article
7.

Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin-tazobactam against selected bacterial isolates recovered from hospitalized patients.

Casellas JM, Tomé G, Bantar C, Bertolini P, Blázquez N, Borda N, Couto E, Cudmani N, Guerrera J, Juárez MJ, López T, Littvik A, Méndez E, Notario R, Ponce G, Quinteros M, Salamone F, Sparo M, Sutich E, Vaylet S, Wolff L.

Diagn Microbiol Infect Dis. 2003 Nov;47(3):527-37.

PMID:
14596972
[PubMed - indexed for MEDLINE]
8.

Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections.

DiNubile MJ, Chow JW, Satishchandran V, Polis A, Motyl MR, Abramson MA, Teppler H.

Antimicrob Agents Chemother. 2005 Aug;49(8):3217-21.

PMID:
16048928
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention.

Dela Pena AS, Asperger W, Köckerling F, Raz R, Kafka R, Warren B, Shivaprakash M, Vrijens F, Giezek H, DiNubile MJ, Chan CY; Optimizing Intra-Abdominal Surgery with Invanz (OASIS)-I Study Group.

J Gastrointest Surg. 2006 Apr;10(4):567-74.

PMID:
16627223
[PubMed - indexed for MEDLINE]
10.

Piperacillin/tazobactam compared with ticarcillin/clavulanate in community-acquired bacterial lower respiratory tract infection.

Shlaes DM, Baughman R, Boylen CT, Chan JC, Charan NB, Cormier YC, Erickson A, Grossman R, Kirmani N, Suh B, et al.

J Antimicrob Chemother. 1994 Oct;34(4):565-77.

PMID:
7868408
[PubMed - indexed for MEDLINE]
11.

Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.

Sweet RL, Roy S, Faro S, O'Brien WF, Sanfilippo JS, Seidlin M.

Obstet Gynecol. 1994 Feb;83(2):280-6.

PMID:
8290195
[PubMed - indexed for MEDLINE]
12.

Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation.

Philpott-Howard J, Burroughs A, Fisher N, Hastings M, Kibbler C, Mutimer D, Patch D, Rolando N, Wade J, Wendon J, O'Grady J.

J Antimicrob Chemother. 2003 Dec;52(6):993-1000. Epub 2003 Oct 29.

PMID:
14585863
[PubMed - indexed for MEDLINE]
Free Article
13.

Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.

Solomkin JS, Yellin AE, Rotstein OD, Christou NV, Dellinger EP, Tellado JM, Malafaia O, Fernandez A, Choe KA, Carides A, Satishchandran V, Teppler H; Protocol 017 Study Group.

Ann Surg. 2003 Feb;237(2):235-45.

PMID:
12560782
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

An open, multicenter clinical trial of piperacillin/tazobactam in the treatment of pediatric patients with intra-abdominal infections.

Arguedas A, Sifuentes-Osornio J, Loaiza C, Herrera M, Corrales JC, Mohs E.

J Chemother. 1996 Apr;8(2):130-6.

PMID:
8708744
[PubMed - indexed for MEDLINE]
15.
16.

Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial.

Alvarez-Lerma F, Insausti-Ordeñana J, Jordá-Marcos R, Maraví-Poma E, Torres-Martí A, Nava J, Martínez-Pellús A, Palomar M, Barcenilla F; Spanish Collaborative Group for the Study of Severe Infections.

Intensive Care Med. 2001 Mar;27(3):493-502.

PMID:
11355117
[PubMed - indexed for MEDLINE]
17.

Piperacillin/tazobactam in the treatment of community-acquired and nosocomial respiratory tract infections: a review.

Sanders CV Jr.

Intensive Care Med. 1994 Jul;20 Suppl 3:S21-6.

PMID:
7962985
[PubMed - indexed for MEDLINE]
18.

Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections.

Brismar B, Malmborg AS, Tunevall G, Wretlind B, Bergman L, Mentzing LO, Nyström PO, Kihlström E, Bäckstrand B, Skau T, et al.

Antimicrob Agents Chemother. 1992 Dec;36(12):2766-73.

PMID:
1336347
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Piperacillin/tazobactam in comparison with clindamycin plus gentamicin in the treatment of intra-abdominal infections.

Shyr YM, Lui WY, Su CH, Wang LS, Liu CY.

Zhonghua Yi Xue Za Zhi (Taipei). 1995 Aug;56(2):102-8.

PMID:
7553416
[PubMed - indexed for MEDLINE]
20.

Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.

Taneja N, Rao P, Arora J, Dogra A.

Indian J Med Res. 2008 Jan;127(1):85-8.

PMID:
18316858
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk